Moderate lifelong overexpression of tuberous sclerosis complex 1 (TSC1) improves health and survival in mice
Abstract The tuberous sclerosis complex 1/2 (TSC1/2) is an endogenous regulator of the mechanistic target of rapamycin (mTOR). While mTOR has been shown to play an important role in health and aging, the role of TSC1/2 in aging has not been fully investigated. In the current study, a constitutive TS...
Guardado en:
Autores principales: | Hong-Mei Zhang, Vivian Diaz, Michael E. Walsh, Yiqiang Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96ca9655468d43eba1428c6922390f67 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Detection of TSC1/TSC2 mosaic variants in patients with cardiac rhabdomyoma and tuberous sclerosis complex by hybrid‐capture next‐generation sequencing
por: Siyu Wang, et al.
Publicado: (2021) -
Comprehensive Genetic Analysis Results of TSC1/TSC2 Genes in Patients with Clinical Suspicion of Tuberous Sclerosis Complex and Definition of 3 Novel Variants
por: Selma Demir, et al.
Publicado: (2021) -
The genomic landscape of tuberous sclerosis complex
por: Katie R. Martin, et al.
Publicado: (2017) -
Regulation of PERK–eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes
por: Minqing Jiang, et al.
Publicado: (2016) -
Correction: Corrigendum: Regulation of PERK–eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes
por: Minqing Jiang, et al.
Publicado: (2016)